Latest News about MRNA
Recent news which mentions MRNA
From Benzinga
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
February 25, 2022
From InvestorPlace
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
February 25, 2022
From Benzinga
10 Biggest Price Target Changes For Friday
February 25, 2022
From Benzinga
88 Biggest Movers From Yesterday
February 25, 2022
From Benzinga
Moderna Rallies After Q4 Earnings: What 2 Analysts Have To Say About COVID-19 Stock
February 24, 2022
Tickers
MRNA
From Benzinga
Nasdaq Stages Epic Intraday Recovery After Russia Invades Ukraine; Adobe, Moderna Lead Boost
February 24, 2022
From Benzinga
Moderna Inc. (MRNA) Q4 2021 Earnings Call Transcript
February 24, 2022
Tickers
MRNA
From Motley Fool
From MarketWatch
Mid-Afternoon Market Update: Nasdaq Surges 2%; South Jersey Industries Shares Spike Higher
February 24, 2022
From Benzinga
Will Moderna Be 'One Of The Most Valuable Healthcare Companies' In The World? Steve Weiss Believes So
February 24, 2022
Tickers
MRNA
From Benzinga
2 Nasdaq Stocks Rising Big in Thursday's Market Swoon
February 24, 2022
From Motley Fool
Mid-Day Market Update: Dow Drops Over 500 Points; Crude Oil Surges 6%
February 24, 2022
From Benzinga
Moderna expects COVID to become endemic in 2023, and Los Angeles County is latest to unveil plan to end face-mask mandates indoors
February 24, 2022
Tickers
MRNA
Tags
MRNA
From MarketWatch
Mid-Morning Market Update: US Markets Open Lower Amid Russian Military Action In Ukraine
February 24, 2022
From Benzinga
Swallow your fear and prepare for a ‘relief rally,’ says analyst, as Russia invasion in Ukraine sparks stock-market maelstrom
February 24, 2022
From MarketWatch
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales
February 24, 2022
Tickers
MRNA
From Benzinga
Novavax Is a Buy on Recent Developments and Cheap Valuation
February 24, 2022
From InvestorPlace
4 Pharma Stocks to Buy Even if the Pandemic Ends
February 24, 2022
From InvestorPlace
A Peek Into The Markets: US Stock Futures Plunge As Russia Attacks Ukraine; Dow Futures Down 600 Points
February 24, 2022
From Benzinga
5 Stocks To Watch For February 24, 2022
February 24, 2022
From Benzinga
Why Novavax Stock Dived by Over 7% Today
February 23, 2022
From Motley Fool
Why Moderna Stock Is Falling Today
February 23, 2022
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.